Language

English

Publication Date

4-9-2026

Journal

Breast Cancer Research

DOI

10.1186/s13058-026-02273-0

PMID

41957809

PMCID

PMC13181999

PubMedCentral® Posted Date

4-9-2026

PubMedCentral® Full Text Version

Post-print

Abstract

Background: The cumulative risk of contralateral breast cancer (CBC) in BRCA1/2 carriers is remarkably higher than in non-carriers. This study aimed to investigate the clinicopathological predictors associated with the risk of metachronous CBC among breast cancer patients with BRCA1/2 mutations using correspondence analysis.

Methods: This retrospective study included patients who underwent BRCA testing between January 2008 and December 2018. The inclusion criterion was patients being between 20 and 80-years-old with invasive breast cancer (pT1-3, N0-3). We performed univariate and multivariate survival analyses to assess the risks associated with BRCA mutations, and conducted correspondence analysis to identify contributing factors for CBC among subgroup by age and BRCA mutations.

Results: Total of 4009 patients were included in this analysis. After median follow-up of 93 months, 278 cases of CBC were documented. Among 576 patients with BRCA mutations, there was no difference in the incidence of CBC between BRCA1 and BRCA2 carriers (P = 0.07). Correspondence analysis revealed that, in younger patients (< 50 years) with BRCA1 mutations, the triple-negative subtype (r = 0.93) and high grade (r = 0.74) showed the closest geometric proximity associated with CBC. In BRCA2 carriers, high Ki-67 labeling index (≥ 20%) demonstrated prominent geometric association in the biplot related to CBC, regardless of age (r = 0.93).

Conclusion: Although no difference was found in the risk of CBC between BRCA 1/2 mutations, correspondence analysis revealed different contributing factors. For young BRCA carriers with a triple-negative subtype and poor pathologic parameters such as high grade and Ki-67 index, risk-reducing contralateral prophylactic mastectomy could be considered as a treatment strategy.

Keywords

Humans, Female, Middle Aged, Breast Neoplasms, Adult, Retrospective Studies, Aged, Mutation, BRCA2 Protein, Republic of Korea, BRCA1 Protein, Neoplasms, Second Primary, Aged, 80 and over, Risk Factors, Prognosis, Genetic Predisposition to Disease, Young Adult, Breast cancer, BRCA mutation, Prophylactic surgery, Prognostic factor

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.